AI Labs Confront Biological Risk Testing Gap
Source: Financial Times (paywall)
Frontier labs including Anthropic, OpenAI, and Google DeepMind are building evaluation frameworks for AI-assisted bioweapon development—but this risk category resists the clean, reproducible testing that cybersecurity enjoys. Unlike digital exploits, biological threat validation requires either actual lab work (ethically fraught) or simulation-based proxies (potentially unreliable), leaving regulators and companies with asymmetric confidence in their safety claims. Capability control now hinges on the hardest-to-test attack surface, not the easiest.